CA-BIOCYTOGEN
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that it has entered into an antibody evaluation and option agreement with Neurocrine Biosciences, Inc. The agreement grants Neurocrine Biosciences access to Biocytogen’s fully human antibodies against multiple specified targets, with an option to license selected antibodies for therapeutic product development, manufacturing and commercialization for all uses worldwide. Additional targets may be included under this agreement subject to mutual agreement. The antibodies were generated by Biocytogen’s proprietary RenMice® platforms.
Under the terms of the agreement, if options are exercised, Biocytogen will be entitled to option-exercise fees, development and commercialization milestone payments, as well as single-digit royalties on net sales for each selected target.
Dr. Yuelei Shen, President and CEO of Biocytogen, said, “We are pleased that our RenMice®-derived fully human antibodies received recognition from Neurocrine Biosciences, a world-leading neuroscience-focused biopharmaceutical company. We are optimistic that the combination of our comprehensive, validated off-the-shelf antibody sequences and Neurocrine’s extensive experience in novel drug development will accelerate the path to help conquer neurological diseases that are difficult to treat.”
“We are excited to evaluate the therapeutic potential of antibodies generated from Biocytogen’s renowned fully human antibody platforms,” said Jude Onyia, Ph.D., Chief Scientific Officer at Neurocrine Biosciences. “We believe this collaboration will help expand our pipeline with antibody-based drugs and ultimately provide patients with improved treatment options.”
About Biocytogen
Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® (RenMabTM/RenLite®/RenNano®/RenTCR-mimicTM) platforms for fully human monoclonal/bispecific/multispecific antibody discovery, bispecific antibody-drug conjugate discovery, nanobody discovery and TCR-mimic antibody discovery, and has established an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. As of June 30, 2023, 50 therapeutic antibody and multiple clinical asset co-development/out-licensing/transfer agreements and 42 target-nominated RenMice® licensing projects have been established around the globe, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMiceTM, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA (Boston, San Francisco), and Germany (Heidelberg). For more information, please visit http://en.biocytogen.com.cn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231219983706/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Business Reply and Pusterla 1880: Global Digital Transformation in Luxury Packaging with Oracle Cloud3.10.2025 10:00:00 CEST | Press release
Business Reply, the Reply company specialized in the implementation of enterprise solutions based on Oracle technologies, supported Pusterla 1880 — an international leader in the luxury packaging sector — in a digital transformation project aimed at standardizing and optimizing financial, logistics, and production processes on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251003867603/en/ With the support of Business Reply, Pusterla 1880 adopted a fully integrated solution on Oracle Cloud, enabling the harmonization of operational workflows on a global scale. With over 140 years of experience and a continuously expanding presence across Europe, Asia, and the Americas, Pusterla 1880 operates in a sector that demands high standards of customization, quality, and precision. End-to-end supply chain traceability is a strategic element for ensuring full control over the entire production cycle, from the management
Downtown UAQ | Sobha Realty Sells Over 50% of Launch Inventory Within First Week3.10.2025 08:00:00 CEST | Press release
Sobha Realty has announced strong initial sales at its flagship Downtown UAQ | Sobha Realty master development, reinforcing rising investor confidence in Umm Al Quwain as the UAE’s next coastal growth hub. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002867954/en/ Downtown UAQ | Sobha Realty (Photo: AETOSWire) Within just one week of its launch, the developer confirmed that over 50% of units in the first three residential towers were sold, setting a new benchmark for sales velocity in the northern emirates. The 25-million-square-foot master development, located along Umm Al Quwain’s natural waterfront, is envisioned as the Coastal Skyline of the Future. The project integrates premium residences, commercial hubs, hospitality offerings, and lifestyle amenities to create an exceptional living experience. It is designed to balance modern living with environmental stewardship, with more than half of the total land area dedic
Fanatics Collectibles and Kayou Join Forces to Bring NBA Trading Cards to China3.10.2025 04:00:00 CEST | Press release
NBA Match Attax 2025 to launch on Oct. 3 at retail locations across ChinaFanatics Collectibles kicks off licensed basketball with presence at NBA China Games Fanatics Collectibles, via Topps, and Kayou have announced today a partnership to provide NBA trading cards to China through NBA Match Attax 2025. The deal represents a landmark product offering accessible NBA trading cards for basketball fans in China and further growing the country’s passion for the sport. As part of the deal, Kayou, a leading trading card manufacturer in China, will handle the manufacturing and distribution of the product, leveraging its expansive existing distribution network, while Topps will utilize its world class design to delight Chinese fans and collectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002665209/en/ The deal underscores Fanatics Collectibles’ commitment to growing the Chinese market, as well as its international growth str
With the Redevelopment Works Underway, UCC Holding on behalf of the JV Partners Signs Five Design and Consultancy Agreements with Global Firms for the Development of Damascus International Airport2.10.2025 20:37:00 CEST | Press release
UCC Holding, on behalf of the JV partners and through its subsidiary Urbacon Airports, has signed five consultancy and design agreements as part of the Damascus International Airport comprehensive redevelopment project. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002746016/en/ UCC Holding on behalf of the JV Partners Signs Five Design and Consultancy Agreements with Global Firms for the Development of Damascus International Airport (Photo: AETOSWire) Scopes include the redevelopment of the airport and all associated facilities — a phased redevelopment designed to reach 31 million passengers annually. This includes the refurbishment of existing terminals and buildings, as well as the design and development of a new five-star hotel adjacent to the airport, featuring 200 premium rooms, multiple dining and leisure facilities, and direct terminal access. The hotel will be managed and operated by an internationally recognize
Stefanini Group Ranked Exceptional Performer for Customer Satisfaction by Whitelane 2025 Swiss IT Sourcing Study2.10.2025 19:52:00 CEST | Press release
The tech company achieved the highest general satisfaction ranking with scores of 85% in the Whitelane Research study. Stefanini Group, a global technology company specializing in digital transformation and AI solutions, announced today that it was awarded the title “Exceptional Performer” for General Customer Satisfaction and Workplace Services in the Whitelane 2025 Swiss IT Sourcing Study. Debuting in the research this year, Stefanini achieved the highest general satisfaction ranking with scores of 85%, compared to the industry average of 78 percent. The company was also ranked number one for Workplace Services (83% vs. 79% industry average), considering several key performance indicators (KPIs). “All Stefanini KPI scores are great, but Account Management is truly outstanding (94% compared with 79% industry average). This KPI evaluates how Stefanini manages their relationship with clients, from a strategic and commercial perspective, and identifies new areas for cooperation and impro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom